Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Jeffrey Hing Jun Xian

Clin Asst Prof Hing Jeffrey Jun Xian

MBBS, MRCS, MMED, FRCSEd (Gen Surg), FAMS

Consultant

Changi General Hospital

Specialty: General Surgery

Conditions Treated by this Doctor:
3D-breast Tomosynthesis, Atypical Hyperplasia, Breast Cancer, Breast Cancer (Breast Health), Breast Cancer and Reconstruction, Breast Infection, Breast Lumps, Breast Pain, Breast Reconstruction, Breast Screening – Self-Exam and Mammogram, Digital Mammography, Duct Ectasia, Fibroadenoma, Fibrocystic Change, Gynaecomastia, Intraductal Papillomas, Lobular Carcinoma in Situ, Mammography, Mammography, MRI-Guided Breast Biopsies, Nipple Discharge, Oncoplastic Breast Surgery, Phyllodes Tumour, Ultrasonography, Ultrasound Breast Elastography, Vacuum-Assisted Breast Biopsy.

Clinical Appointments

  • Consultant Surgery Changi General HospitalChangi General Hospital
  • Consultant Breast Surgery Changi General HospitalChangi General Hospital
  • Consultant SingHealth Duke-NUS Breast Centre

Profile

Dr Jeffrey Hing Jun Xian graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Monash University, Australia, in 2012 and completed the Singhealth General Surgery Residency Programme in 2019. He was accredited as a specialist in general surgery in september 2019 and became a fellow of the Royal College of Surgeons of Edinburgh FRCSEd (Gen Surg) before sub-specialising in breast surgery.

His areas of interest are in the management of breast cancer and to contribute to the field of holistic care for breast cancer patients.

Education

  • Fellow of Royal College of Surgeons (Edinburgh) - 2019
  • Master of Medicine (Surgery) – 2017
  • Bachelor Of Medicine and Bachelor of Surgery with Honors – 2012 (Monash University)

Professional Appointments and Committee Memberships

  • Fellow, Academy of Medicine, Singapore - 2020
  • Fellow of Royal College of Surgeons (Edinburgh) - 2019
  • Member of Royal College of Surgeons, Edinburgh – 2014

Awards

Research Interests

2018
  • Utility of tumour marker velocity of cancer antigen 15-3 (CA15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance, October 2018. Presented in Melbourne International Breast Congress 2018 (Melbourne, Australia)
2017
  • Greater compliance within instruction-for-use for concomitant iliac aneurysms and adverse aneurysm characeristics – Initial Experience with the Nellix Endovascular Aneurysm Sealing System (EVAS) at a single institution, Feb 2017. Presented in Vascular Endovascular Surgery Society Meeting 2017 (Colorado, USA)

Publications

2019
  • Single Port 3-Dimensional (3D) Endoscopic Subcutaneous Mastectomy for Gynaecomastia – An Aesthetically Superior and Novel Approach, Mok CW, Hing JX, Tan SM, Mini-invasive Surg 2019;3:40
  • Limb stent occlusion from intraoperative Nellix stent migration and prolapse, Hing JX, Chng JK, Tay KH, Chong TT, Ann Vasc Surg, 2019 Jan;54:144
2018
  • Greater compliance within instruction-for-use for concomitant iliac aneurysms and adverse aneurysm characeristics – Initial Experience with the Nellix Endovascular Aneurysm Sealing System (EVAS) at a single institution, Hing JX, Chng JK, Tay KH, Chong TT, Ann Vasc Surg. 2018 Feb 9
2014
  • Haemolysis: the harbinger of recurrent mitral regurgitation after mitral valve repair, Hing JX, Macy A, Elshiekh MA, Momin A, Koertzen M, Punjabi PP, Perfusion. 2014 Mar;29(2):184-6

Research Trials